Fortive Corp - Understand $ftv stock

$FTV Market Cap: $27.35 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$6.195B

TTM

Gross Margin

59.75%

TTM

Net Earnings

$889.3M

TTM

Current Assets

$2.635B

Q3 2024

Current Liabilities

$2.101B

Q3 2024

Current Ratio

125.44%

Q3 2024

Total Assets

$17.45B

Q3 2024

Total Liabilities

$6.892B

Q3 2024

Book Value

$10.56B

Q3 2024

Cash

$811.3M

Q3 2024

P/E

30.75

Nov 29, 2024 EST

Free Cash Flow

$1.354B

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	$6.065B	$5.826B	$5.255B	$4.634B	$4.564B	$6.453B	$5.756B	$5.378B	$6.179B	$6.337B	$5.962B	$5.785B
YoY Change	4.11%	10.87%	13.38%	1.54%	-29.27%	12.1%	7.03%	-12.96%	-2.5%	6.29%	3.05%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	$6.065B	$5.826B	$5.255B	$4.634B	$4.564B	$6.453B	$5.756B	$5.378B	$6.179B	$6.337B	$5.962B	$5.785B
Cost Of Revenue	$2.471B	$2.462B	$2.248B	$2.026B	$2.081B	$1.614B	$2.835B	$2.693B	$3.179B	$3.288B	$3.088B	$3.002B
Gross Profit	$3.594B	$3.363B	$3.007B	$2.609B	$2.483B	$2.186B	$2.921B	$2.686B	$3.000B	$3.049B	$2.874B	$2.784B
Gross Profit Margin	59.26%	57.73%	57.23%	56.29%	54.41%	33.88%	50.75%	49.93%	48.55%	48.12%	48.21%	48.11%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Selling, General & Admin	$2.063B	$1.957B	$1.840B	$1.748B	$1.719B	$1.263B	$1.409B	$1.273B	$1.353B	$1.416B	$1.324B	$1.260B
YoY Change	5.42%	6.37%	5.21%	1.71%	36.13%	-10.38%	10.71%	-5.9%	-4.5%	6.95%	5.07%
% of Gross Profit	57.39%	58.17%	61.17%	67.03%	69.23%	57.76%	48.23%	47.4%	45.09%	46.45%	46.08%	45.28%
Research & Development	$397.8M	$401.5M	$354.8M	$320.7M	$320.3M	$278.1M	$369.3M	$351.0M	$377.7M	$387.6M	$378.3M	$352.7M
YoY Change	-0.92%	13.16%	10.63%	0.12%	15.17%	-24.7%	5.21%	-7.07%	-2.55%	2.46%	7.26%
% of Gross Profit	11.07%	11.94%	11.8%	12.29%	12.9%	12.72%	12.64%	13.07%	12.59%	12.71%	13.16%	12.67%
Depreciation & Amortization	$456.8M	$465.6M	$395.5M	$384.0M	$341.5M	$174.2M	$158.3M	$160.9M	$176.9M	$178.0M	$159.7M	$145.0M
YoY Change	-1.89%	17.72%	2.99%	12.45%	96.04%	10.04%	-1.62%	-9.04%	-0.62%	11.46%	10.14%
% of Gross Profit	12.71%	13.84%	13.15%	14.72%	13.75%	7.97%	5.42%	5.99%	5.9%	5.84%	5.56%	5.21%
Operating Expenses	$2.460B	$2.358B	$2.194B	$2.069B	$2.039B	$1.541B	$1.778B	$1.624B	$1.730B	$1.804B	$1.703B	$1.613B
YoY Change	4.34%	7.46%	6.05%	1.46%	32.34%	-13.35%	9.52%	-6.16%	-4.08%	5.95%	5.55%
Operating Profit	$1.134B	$987.4M	$812.8M	$539.4M	$443.9M	$645.3M	$1.143B	$1.062B	$1.270B	$1.245B	$1.172B	$1.170B
YoY Change	14.82%	21.48%	50.69%	21.51%	-31.21%	-43.54%	7.66%	-16.38%	1.96%	6.3%	0.09%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Interest Expense	-$123.5M	$98.30M	$103.2M	$148.5M	$142.6M	$77.20M	$88.70M	$46.40M	$0.00	$0.00
YoY Change	-225.64%	-4.75%	-30.51%	4.14%	84.72%	-12.97%	91.16%
% of Operating Profit	-10.89%	9.96%	12.7%	27.53%	32.12%	11.96%	7.76%	4.37%	0.0%	0.0%
Other Income/Expense, Net	-$19.40M	-$15.60M	-$14.10M	-$2.400M	-$5.400M	-$2.300M	$4.000M	-$4.800M
YoY Change	24.36%	10.64%	487.5%	-55.56%	134.78%	-157.5%	-183.33%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Pretax Income	$990.8M	$873.5M	$677.5M	$1.508B	$336.7M	$565.8M	$1.074B	$1.011B	$1.270B	$1.279B	$1.143B	$1.128B
YoY Change	13.43%	28.93%	-55.06%	347.79%	-40.49%	-47.3%	6.24%	-20.41%	-0.74%	11.9%	1.37%
Income Tax	$125.0M	$118.3M	$63.30M	$55.50M	$68.60M	$75.60M	$189.3M	$270.3M	$405.9M	$395.8M	$312.3M	$364.1M
% Of Pretax Income	12.62%	13.54%	9.34%	3.68%	20.37%	13.36%	17.63%	26.75%	31.97%	30.94%	27.32%	32.28%
Net Earnings	$865.8M	$755.2M	$608.4M	$1.613B	$738.9M	$2.914B	$1.045B	$872.3M	$863.8M	$883.4M	$830.9M	$763.7M
YoY Change	14.65%	24.13%	-62.29%	118.34%	-74.64%	178.97%	19.74%	0.98%	-2.22%	6.32%	8.8%
Net Earnings / Revenue	14.27%	12.96%	11.58%	34.81%	16.19%	45.16%	18.15%	16.22%	13.98%	13.94%	13.94%	13.2%
Basic Earnings Per Share	$2.46	$2.12	$1.64	$4.58	$1.99	$8.33	$3.01	$2.52	$2.50	$2.56
Diluted Earnings Per Share	$2.44	$2.10	$1.63	$4.49	$1.97	$8.21	$2.96	$2.51	$2.50	$2.56	$2.415M	$2.220M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Short-Term Investments	$1.889B	$709.2M	$819.3M	$2.944B	$1.205B	$1.178B	$962.0M	$803.0M
YoY Change	166.33%	-13.44%	-72.17%	144.32%	2.29%	22.45%	19.8%
Cash & Equivalents	$1.889B	$709.2M	$819.3M	$1.825B	$1.205B	$1.178B	$962.0M	$803.0M
Short-Term Investments			$0.00	$1.119B
Other Short-Term Assets	$285.1M	$272.6M	$252.7M	$237.0M	$459.0M	$223.0M	$251.0M	$196.0M	$92.00M	$216.0M	$249.0M
YoY Change	4.59%	7.87%	6.62%	-48.37%	105.83%	-11.16%	28.06%	113.04%	-57.41%	-13.25%
Inventory	$536.9M	$536.7M	$512.7M	$456.0M	$640.0M	$575.0M	$581.0M	$545.0M	$523.0M	$511.0M	$495.0M
Prepaid Expenses
Receivables	$960.8M	$958.5M	$930.2M	$810.0M	$1.385B	$1.195B	$1.144B	$945.0M	$979.0M	$956.0M	$912.0M
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.672B	$2.477B	$2.515B	$4.447B	$3.689B	$3.171B	$2.937B	$2.489B	$1.594B	$1.683B	$1.655B
YoY Change	48.23%	-1.51%	-43.45%	20.55%	16.34%	7.97%	18.0%	56.15%	-5.29%	1.69%
Property, Plant & Equipment	$439.8M	$421.9M	$571.1M	$611.0M	$726.0M	$576.0M	$713.0M	$548.0M	$515.0M	$481.0M	$455.0M
YoY Change	4.24%	-26.13%	-6.53%	-15.84%	26.04%	-19.21%	30.11%	6.41%	7.07%	5.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$518.9M	$455.8M	$337.3M	$344.0M	$780.0M	$549.0M	$477.0M	$427.0M	$206.0M	$189.0M	$165.0M
YoY Change	13.84%	35.13%	-1.95%	-55.9%	42.08%	15.09%	11.71%	107.28%	8.99%	14.55%
Total Long-Term Assets	$13.24B	$13.41B	$13.95B	$11.61B	$13.75B	$9.735B	$7.564B	$5.701B	$5.617B	$5.673B	$5.585B
YoY Change	-1.29%	-3.85%	20.21%	-15.6%	41.24%	28.7%	32.68%	1.5%	-0.99%	1.58%
Total Assets	$16.91B	$15.89B	$16.47B	$16.05B	$17.44B	$12.91B	$10.50B	$8.190B	$7.211B	$7.356B	$7.240B
YoY Change
Accounts Payable	$608.6M	$623.0M	$557.9M	$481.0M	$766.0M	$707.0M	$728.0M	$666.0M	$657.0M	$623.0M	$617.0M
YoY Change	-2.31%	11.67%	15.99%	-37.21%	8.35%	-2.88%	9.31%	1.37%	5.46%	0.97%
Accrued Expenses	$1.183B	$284.5M	$302.3M	$314.0M	$323.0M	$252.0M	$280.0M	$212.0M	$208.0M	$205.0M	$208.0M
YoY Change	315.71%	-5.89%	-3.73%	-2.79%	28.17%	-10.0%	32.08%	1.92%	1.46%	-1.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$549.3M	$999.7M	$2.152B	$1.400B	$1.500B	$456.0M
YoY Change	-45.05%	-53.54%	53.69%	-6.67%	228.95%
Total Short-Term Liabilities	$2.341B	$2.727B	$3.715B	$2.861B	$3.467B	$2.192B	$1.602B	$1.467B	$1.324B	$1.285B	$1.277B
YoY Change	-14.17%	-26.59%	29.85%	-17.48%	58.17%	36.83%	9.2%	10.8%	3.04%	0.63%
Long-Term Debt	$3.097B	$2.252B	$1.807B	$2.830B	$4.828B	$2.975B	$4.056B	$3.358B	$0.00	$0.00	$0.00
YoY Change	37.54%	24.58%	-36.14%	-41.38%	62.29%	-26.65%	20.79%
Other Long-Term Liabilities	$1.149B	$1.223B	$1.426B	$1.388B	$1.743B	$1.126B	$1.034B	$674.0M	$705.0M	$838.0M	$838.0M
YoY Change	-6.07%	-14.23%	2.76%	-20.37%	54.8%	8.9%	53.41%	-4.4%	-15.87%	0.0%
Total Long-Term Liabilities	$4.246B	$3.475B	$3.234B	$4.218B	$6.571B	$4.101B	$5.090B	$4.032B	$705.0M	$838.0M	$838.0M
YoY Change	22.19%	7.46%	-23.34%	-35.81%	60.23%	-19.43%	26.24%	471.91%	-15.87%	0.0%
Total Liabilities	$6.593B	$6.207B	$6.953B	$7.087B	$10.05B	$6.310B	$6.710B	$5.502B	$2.031B	$2.126B	$2.117B
YoY Change	6.21%	-10.73%	-1.89%	-29.5%	59.3%	-5.96%	21.96%	170.9%	-4.47%	0.43%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Basic Shares Outstanding	352.5M shares	356.4M shares	349.0M shares	337.4M shares	335.8M shares	345.5M shares	347.5M shares	345.7M shares	345.2M shares	345.2M shares
Diluted Shares Outstanding	355.6M shares	360.8M shares	352.3M shares	359.0M shares	340.0M shares	350.7M shares	352.6M shares	347.3M shares	345.2M shares	345.2M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $27.35 Billion

About Fortive Corp

Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. The company is headquartered in Everett, Washington and currently employs 18,000 full-time employees. The company went IPO on 2016-06-13. Its segments include Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment offers advanced instrumentation, software, and services, such as electrical test and measurement, facility, and asset lifecycle software applications, connected worker safety and compliance solutions across a range of vertical end markets, such as manufacturing, process industries, and healthcare. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies offered across a range of vertical end markets, such as automotive and medical equipment. The Advanced Healthcare Solutions segment offers instrument sterilization solutions, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation detection and safety monitoring.

Industry: Industrial Instruments For Measurement, Display, and Control Peers: DOVER Corp Ingersoll Rand Inc. IDEX CORP /DE/ ILLINOIS TOOL WORKS INC Xylem Inc. NORDSON CORP Otis Worldwide Corp PARKER HANNIFIN CORP STANLEY BLACK & DECKER, INC.